First-line treatment with pulsed field ablation (PFA) reduced the risk of recurrence of atrial arrhythmia among patients with persistent atrial fibrillation (Afib), the randomized AVANT GUARD trial ...
A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced ...
Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...
Shares of Abbott Laboratories Inc. ABT moved higher in Monday's premarket session after the company unveiled new clinical ...
Add Yahoo as a preferred source to see more of our stories on Google. Owensboro Health Regional Hospital took a significant step forward last week in the treatment of patients with atrial fibrillation ...
There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...
Pulse Biosciences is positioning its nanosecond PFA technology as a game-changer in the competitive atrial fibrillation ...
DEAR MAYO CLINIC: I have atrial fibrillation, and I've heard there's a new kind of ablation that could relieve my symptoms. Can you tell me about it? ANSWER: If you have atrial fibrillation (AFib), ...
Rhythm (Nasdaq:IRTC) today announced findings from two real-world analyses supporting its long-term heart monitoring ...
Johnson & Johnson (NYSE:JNJ) has entered a definitive agreement to acquire Atraverse Medical, a developer of next-generation ...
Real-world data presented at HRS 2026 add to the body of evidence supporting a shift away from short-duration Holter monitoring toward up to 14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results